PULMONX CORPORATION Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs
PULMONX CORPORATION (LUNG) reported Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs of $1.80 million for the 1-month period ending 2020-05-31, per its 10-K filed 2022-03-01.
Discontinued › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts · last filed 2022-03-01
- 2020-05-31: Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs 1 month $1.80M.
| Period end | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs 1 month |
|---|---|
| 2020-05-31 | $1.80M 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |